Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Giulia Ribelli"'
Autor:
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell’Aquila, Cecilia Anesi, Nicola Silvestris, Antonella Argentiero, Antonio Solimando, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-13 (2020)
Abstract In a large number of cancer types, treatment selection depends on the presence of specific tumor biomarkers. Due to the dynamic nature of cancer, very often these predictive biomarkers are not uniformly present in all cancer cells. Tumor het
Externí odkaz:
https://doaj.org/article/df30fbd5545649af9ad98954967d60dd
Autor:
Giulia Ribelli, Sonia Simonetti, Michele Iuliani, Elisabetta Rossi, Bruno Vincenzi, Giuseppe Tonini, Francesco Pantano, Daniele Santini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Patients with metastatic prostate cancer frequently develop bone metastases that elicit significant skeletal morbidity and increased mortality. The high tropism of prostate cancer cells for bone and their tendency to induce the osteoblastic-like phen
Externí odkaz:
https://doaj.org/article/997e7bc7ecd848bdac9b104e3b8c09f1
Autor:
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Silvia Cavaliere, Bruno Vincenzi, Giuseppe Tonini, Francesco Pantano, Daniele Santini
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2154 (2022)
Abiraterone is a selective inhibitor of androgen biosynthesis approved for the treatment of metastatic patients affected by castration-resistant or castration-sensitive prostate cancer. Intriguingly, clinical data revealed that abiraterone also delay
Externí odkaz:
https://doaj.org/article/2bf05cdd644e42869ddd9d73ce40987b
Autor:
Francesco Pantano, Francesca Zalfa, Michele Iuliani, Sonia Simonetti, Paolo Manca, Andrea Napolitano, Simone Tiberi, Marco Russano, Fabrizio Citarella, Simone Foderaro, Elisabetta Vulpis, Alessandra Zingoni, Laura Masuelli, Roberto Bei, Giulia Ribelli, Marzia Del Re, Romano Danesi, Bruno Vincenzi, Giuseppe Perrone, Giuseppe Tonini, Daniele Santini
Publikováno v:
Cancers, Vol 14, Iss 10, p 2435 (2022)
Immune checkpoint inhibitors (ICIs) are largely used in the treatment of patients with advanced non-small-cell lung cancer (NSCLC). Novel biomarkers that provide biological information that could be useful for clinical management are needed. In this
Externí odkaz:
https://doaj.org/article/05614305544c469f887d25f0f5a5132b
Autor:
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Andrea Napolitano, Umile Giuseppe Longo, Bruno Vincenzi, Paolo Orsaria, Vincenzo Denaro, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2477 (2022)
The CDK4/6 inhibitors (CDKi) palbociclib, ribociclib, and abemaciclib are currently approved in combination with anti-estrogen therapy for the treatment of advanced and/or metastatic hormone receptor-positive/HER2-neu-negative breast cancer patients.
Externí odkaz:
https://doaj.org/article/7953cd4897cc45de805723ad414d5607
Autor:
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Andrea Napolitano, Francesco Pantano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Bone is one of the preferential sites of distant metastases from malignant tumors, with the highest prevalence observed in breast and prostate cancers. Patients with bone metastases (BMs) may experience skeletal-related events, such as severe bone pa
Externí odkaz:
https://doaj.org/article/abbff2c66f844f42b728eaa3562a365d
Autor:
Michele Iuliani, Sonia Simonetti, Francesco Pantano, Giulia Ribelli, Alberto Di Martino, Vincenzo Denaro, Bruno Vincenzi, Antonio Russo, Giuseppe Tonini, Daniele Santini
Publikováno v:
Biology, Vol 10, Iss 8, p 781 (2021)
Background: The presence of bone metastases in renal cell carcinoma (RCC) negatively affects patients’ survival. Data from clinical trials has highlighted a significant benefit of cabozantinib in bone metastatic RCC patients. Here, we evaluated the
Externí odkaz:
https://doaj.org/article/3793a4c194794a12bc86ad6cc5bcdffa
Autor:
Francesca R. Bertani, Pamela Mozetic, Marco Fioramonti, Michele Iuliani, Giulia Ribelli, Francesco Pantano, Daniele Santini, Giuseppe Tonini, Marcella Trombetta, Luca Businaro, Stefano Selci, Alberto Rainer
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract The possibility of detecting and classifying living cells in a label-free and non-invasive manner holds significant theranostic potential. In this work, Hyperspectral Imaging (HSI) has been successfully applied to the analysis of macrophagic
Externí odkaz:
https://doaj.org/article/1d75aee3c71e4d898809e9c4699d7677
Autor:
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell’Aquila, Cecilia Anesi, Nicola Silvestris, Antonella Argentiero, Antonio Giovanni Solimando, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/0e8ed3ca91904efb88ca18a5508c2752
Autor:
Keltouma Driouch, Sandra Geraci, Michele Iuliani, Philippe Clézardin, Martine Croset, Bruno Vincenzi, Klaus Pantel, Francesco Pantano, Giulia Ribelli, Natalia Bednarz-Knoll, Edith Bonnelye, Daniele Santini, Giuseppe Tonini, Harriet Wikman, Florian Bonin, Sofia Sousa, Saw See Hong, Sonia Simonetti
Publikováno v:
Oncogene
Oncogene, In press, ⟨10.1038/s41388-020-01603-6⟩
Oncogene, Nature Publishing Group, In press, ⟨10.1038/s41388-020-01603-6⟩
Oncogene, In press, ⟨10.1038/s41388-020-01603-6⟩
Oncogene, Nature Publishing Group, In press, ⟨10.1038/s41388-020-01603-6⟩
Bone metastasis remains a major cause of mortality and morbidity in breast cancer. Therefore, there is an urgent need to better select high-risk patients in order to adapt patient’s treatment and prevent bone recurrence. Here, we found that integri